Management of psychogenic non-epileptic seizures: a multidisciplinary approach.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
02 2019
Historique:
received: 24 07 2018
accepted: 04 10 2018
pubmed: 10 10 2018
medline: 19 6 2019
entrez: 10 10 2018
Statut: ppublish

Résumé

The International League against Epilepsy (ILAE) proposed a diagnostic scheme for psychogenic non-epileptic seizure (PNES). The debate on ethical aspects of the diagnostic procedures is ongoing, the treatment is not standardized and management might differ according to age group. The objective was to reach an expert and stakeholder consensus on PNES management. A board comprising adult and child neurologists, neuropsychologists, psychiatrists, pharmacologists, experts in forensic medicine and bioethics as well as patients' representatives was formed. The board chose five main topics regarding PNES: diagnosis; ethical issues; psychiatric comorbidities; psychological treatment; and pharmacological treatment. After a systematic review of the literature, the board met in a consensus conference in Catanzaro (Italy). Further consultations using a model of Delphi panel were held. The global level of evidence for all topics was low. Even though most questions were formulated separately for children/adolescents and adults, no major age-related differences emerged. The board established that the approach to PNES diagnosis should comply with ILAE recommendations. Seizure induction was considered ethical, preferring the least invasive techniques. The board recommended looking carefully for mood disturbances, personality disorders and psychic trauma in persons with PNES and considering cognitive-behavioural therapy as a first-line psychological approach and pharmacological treatment to manage comorbid conditions, namely anxiety and depression. Psychogenic non-epileptic seizure management should be multidisciplinary. High-quality long-term studies are needed to standardize PNES management.

Identifiants

pubmed: 30300463
doi: 10.1111/ene.13818
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-e15

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 EAN.

Auteurs

S Gasparini (S)

Department of Medical and Surgical Sciences, Magna Greacia University of Catanzaro, Catanzaro, Italy.
Regional Epilepsy Centre, Great Metropolitan Hospital of Reggio Calabria, Reggio Calabria, Italy.

E Beghi (E)

Department of Neurosciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

E Ferlazzo (E)

Department of Medical and Surgical Sciences, Magna Greacia University of Catanzaro, Catanzaro, Italy.
Regional Epilepsy Centre, Great Metropolitan Hospital of Reggio Calabria, Reggio Calabria, Italy.
Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy.

M Beghi (M)

Department of Mental Health, AUSL Romagna, Ravenna, Italy.

V Belcastro (V)

Neurology Unit, Department of Medicine, S. Anna Hospital, Como, Italy.

K P Biermann (KP)

Clinical Trial Office, Meyer Children's Hospital, Florence, Italy.

G Bottini (G)

Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.

G Capovilla (G)

Child Neuropsychiatry Unit, Azienda Ospedaliera Carlo Poma, Mantova, Italy.

R A Cervellione (RA)

Italian Federation against Epilepsies, Milan, Italy.

V Cianci (V)

Regional Epilepsy Centre, Great Metropolitan Hospital of Reggio Calabria, Reggio Calabria, Italy.

G Coppola (G)

Child Neuropsychiatry Unit, Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.

C M Cornaggia (CM)

School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.

P De Fazio (P)

Psychiatric Unit, Department of Health Sciences, University 'Magna Graecia', Catanzaro, Italy.

S De Masi (S)

Clinical Trial Office, Meyer Children's Hospital, Florence, Italy.

G De Sarro (G)

Pharmacology Unit, Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.

M Elia (M)

Unit of Neurology and Clinical Neurophysiopathology, Oasi Research Institute - IRCCS, Troina (EN), Italy.

G Erba (G)

Department of Neurology, SEC, University of Rochester, Rochester, NY, USA.

L Fusco (L)

Neurophysiology Unit, Department of Neuroscience, Bambino Gesù Children's Hospital, Rome, Italy.

A Gambardella (A)

Department of Medical and Surgical Sciences, Magna Greacia University of Catanzaro, Catanzaro, Italy.
Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy.

V Gentile (V)

Italian Association Against Epilepsies, Bologna, Italy.

A T Giallonardo (AT)

Neurology Unit, Department of Neuroscience, 'Sapienza' University, Rome, Italy.

R Guerrini (R)

Italian Society of Neurology and Psychiatry of Infancy and Adolescence, Florence, Italy.
Department of Neurosciences, Psychology, Drug Research, and Child Health, University of Florence, Florence, Italy.

F Ingravallo (F)

Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.

A Iudice (A)

Division of Neurology, University of Pisa, Pisa, Italy.

A Labate (A)

Department of Medical and Surgical Sciences, Magna Greacia University of Catanzaro, Catanzaro, Italy.
Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy.

E Lucenteforte (E)

Department of Neurosciences, Psychology, Drug Research, and Child Health, University of Florence, Florence, Italy.

A Magaudda (A)

Epilepsy Centre, University of Messina, Messina, Italy.

L Mumoli (L)

Department of Medical and Surgical Sciences, Magna Greacia University of Catanzaro, Catanzaro, Italy.

C Papagno (C)

CIMeC and CeRiN, University of Trento, Trento, Italy.
Department of Psychology, University of Milano-Bicocca, Milan, Italy.

G B Pesce (GB)

Italian Association Against Epilepsies, Bologna, Italy.

E Pucci (E)

Neurology Unit, ASUR Marche AV3, Macerata, Italy.

P Ricci (P)

University 'Magna Graecia' of Catanzaro, Catanzaro, Italy.

A Romeo (A)

Pediatric Neurology Unit and Epilepsy Center, 'Fatebenefratelli e Oftalmico' Hospital, Milan, Italy.

R Quintas (R)

Clinical and Experimental Epileptology Unit, Neurological Institute Carlo Besta - IRCCS Foundation, Milan, Italy.

C Sueri (C)

Regional Epilepsy Centre, Great Metropolitan Hospital of Reggio Calabria, Reggio Calabria, Italy.

G Vitaliti (G)

University Hospital Policlinico-Vittorio Emanuele, Catania, Italy.

R Zoia (R)

Department of Health and Biomedical Sciences, Section of Legal Medicine, University of Milan, Milan, Italy.

U Aguglia (U)

Department of Medical and Surgical Sciences, Magna Greacia University of Catanzaro, Catanzaro, Italy.
Regional Epilepsy Centre, Great Metropolitan Hospital of Reggio Calabria, Reggio Calabria, Italy.
Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy.
Epilepsy Study Group of Italian Neurology Society, Catanzaro, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH